Long-term survival of renal graft complicated with Burkitt lymphoma

Pediatric Nephrology

Volumn 17, Issue 12, 2002, Pages 1066-1068

  Nathanson, Sylvie ^a   Lucidarme, Nadine ^b   Landman Parker, Judith ^b   Deschênes, Georges ^b  

^a CENTRE HOSPITALIER DE VERSAILLES   (France)

^b ARMAND TROUSSEAU HOSPITAL   (France)

Author keywords

Burkitt lymphoma; Cytarabine toxicity; Prognosis; Renal transplantation

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; DOXORUBICIN; ETOPOSIDE; HYDROCORTISONE; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; STEROID; THYMOCYTE ANTIBODY; VINCRISTINE;

ARTICLE; BURKITT LYMPHOMA; CADAVER KIDNEY; CANCER REGRESSION; CANCER SURVIVAL; CASE REPORT; CEREBELLUM DISEASE; COMBINATION CHEMOTHERAPY; CONVALESCENCE; DISEASE SEVERITY; DRUG MEGADOSE; FOLLOW UP; GRAFT REJECTION; GRAFT SURVIVAL; HEMATOLOGIC DISEASE; HEMODIALYSIS; HUMAN; IMMUNE DEFICIENCY; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MALE; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROTEINURIA; SCHOOL CHILD; SURVIVAL TIME; TUMOR LYSIS SYNDROME;

ANTIMETABOLITES, ANTINEOPLASTIC; BURKITT LYMPHOMA; CREATININE; CYCLOSPORINE; CYTARABINE; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; KIDNEY NEOPLASMS; KIDNEY TRANSPLANTATION; LIVER NEOPLASMS; MALE; NEPHROTIC SYNDROME; SPLENIC NEOPLASMS;

EID: 0036952838     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-002-0992-1     Document Type: Article

References (11)

1. Swerdlow SH (1997) Post-transplant lymphoproliferative disorders working classification. Curr Diagn Pathol 4:28
2. Penn I (1994) De novo malignancy in pediatric organ transplant recipients. J Pediatr Surg 29:221-228
3. Patte C, Michon J, Frappaz D, Leverger G, Rubie H, Soussain C, Pico JL (1994) Therapy of Burkitt and other B-cell acute lymphoblastic leukaemia and lymphoma: experience with the LMB protocols of the SFOP (French Paediatric Oncology Society) in children and adults. Baillieres Clin Haematol 7:339-348
4. Ferrari A, Perroti D, Giardini R, Ghio L, Riva S, Massimino M (1997) Disseminated Burkitt's lymphoma after kidney transplantation: a case report in a boy with Drash syndrome. J Pediatr Hematol Oncol 19:151-155
5. Lohrisch CA, Nevill TJ, Barnett MJ, Hogge DE, Connors JM, Keown PA, Gascoyne RD (2000) Development of a biologically distinct EBV-related lymphoproliferative disorder following autologous bone marrow transplantation for an EBV-negative post-renal allograft Burkitt's lymphoma. Leuk Lymphoma 39:195-201
6. Smets F, Vajro P, Cornu G, Reding R, Otte JB, Sokal EM (2000) Indications and results of chemotherapy in children with posttransplant lymphoproliferative disease after liver transplantation. Transplantation 69:982-984
7. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink HK, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood 84:1361-1392
8. Gasparini M, Rottoli L, Massimino M, Gianni MC, Ballerini E, Ravagnani F, Pupa S, Fossati-Bellani F (1993) Curability of advanced Burkitt's lymphoma in children by intensive short-term chemotherapy. Eur J Cancer 29:692-698
9. Hasle H (1990) Cerebellar toxicity during cytarabine therapy associated with renal insufficiency. Cancer Chemother Pharmacol 27:76-78
10. Damon LE, Mass R, Linker CA (1989) The association between high-dose cytarabine neurotoxicity and renal insufficiency. J Clin Oncol 7:1563-1568
11. Cohen Y, Amir G, Rachmilewitz EA, Polliack A (2002) Sustained complete remission following a combination of very low intensity chemotherapy with Rituximab in an elderly patient with Burkitt's lymphoma. Haematologica 87:ELT04